News

SFGate16d
'Extremely annoying': The persistent cough taking over the Bay Area - SFGATE
She assured me that a cough lasting up to six weeks after a cold is very common — and not a concern to her as a physician if the patient isn’t experiencing any other symptoms.
Medindia23d
Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Sma
PR Newswire DUBLIN, June 10, 2025 Target Action (PDUFA) Date set for October 7, 2025 Application based on data from IMforte, the first Phase 3 trial demonstrating statistically significant and ...
Nasdaq23d
Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small ... - Nasdaq
Application based on data from IMforte, the first Phase 3 trial demonstrating statistically significant and clinically meaningful improvements in both progression-free and overall survival in the ...